Baseline Characteristics of Matched Patients With Type 2 Diabetes Treated With Dipeptidyl Peptidase-4 Inhibitor (DPP-4i), Pioglitazone, Sulfonylurea, or Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Since 2016. Here, SLC5A2 is linked to type 2 diabetes mellitus.